ethyl 3-(5'-fluoro-2'-methoxyphenyl)-2-propenoate | 223778-71-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: ethyl 3-(5'-fluoro-2'-methoxyphenyl)-2-propenoate
• 英文别名: ethyl 3-(2'-methoxy-5'-fluorophenyl)-2-propenoate；ethyl-3-(5'-fluoro-2'-methoxyphenyl)acrylate；ethyl 3-(5-fluoro-2-methoxyphenyl)prop-2-enoate
• CAS: 223778-71-0
• 化学式: C₁₂H₁₃FO₃
• 分子量: 224.232
• InChiKey: IRDMDOBNRAOICM-UHFFFAOYSA-N

物化性质

• 沸点：
  319.4±27.0 °C(Predicted)
• 密度：
  1.149±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 3-(5'-fluoro-2'-methoxyphenyl)-2-propenoate 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 以77%的产率得到6-fluorocoumarin
  参考文献：
  名称：

  An Efficient Large Scale Synthesis of Coumarins by a Dealkylative Boron-Mediated Ring Closure of 3-(Ortho-methoxyaryl)propenoic Esters

  摘要：

  Various substituted coumarins 3 were prepared via a dealkylative boron-mediated ring closure of ortho-methoxycinnamates 2.

  DOI：

  10.1080/00397919908086054
• 作为产物：
  描述：

  2-溴-4-氟苯甲醚 、 丙烯酸乙酯 在 palladium diacetate 、 三(邻甲基苯基)磷 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 ethyl 3-(5'-fluoro-2'-methoxyphenyl)-2-propenoate
  参考文献：
  名称：

  An Efficient Large Scale Synthesis of Coumarins by a Dealkylative Boron-Mediated Ring Closure of 3-(Ortho-methoxyaryl)propenoic Esters

  摘要：

  Various substituted coumarins 3 were prepared via a dealkylative boron-mediated ring closure of ortho-methoxycinnamates 2.

  DOI：

  10.1080/00397919908086054

文献信息

• 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors
  作者：Troy Voelker、Haiji Xia、Keith Fandrick、Robert Johnson、Aaron Janowsky、John R. Cashman

  DOI：10.1016/j.bmc.2009.01.023

  日期：2009.3

  were prepared based on (−)-cocaine and aryltropanes as lead compounds because they are reasonably potent 5-HT re-uptake inhibitors. Molecular dissection of an aryltropane provided a series of 5- and 6-membered ring compounds. From among this library of compounds a series of disubstituted tetrahydrofurans bearing 2-alkyl aryl and 5-alkyl amino groups were identified as having highly potent and selective

  5-羟色胺（5-HT，5-羟色胺）神经传递的增强是治疗抑郁症的可行方法。基于该观察结果，基于（-）-可卡因和芳基环烷类作为先导化合物，制备了抑制5-HT再摄取的药物，因为它们是有效的5-HT再摄取抑制剂。芳基托烷的分子分解提供了一系列的5元和6元环化合物。从该化合物库中，鉴定出一系列带有2-烷基芳基和5-烷基氨基的二取代四氢呋喃具有高度有效和选择性的5-HT再摄取抑制作用。评价化合物与放射性标记的RTI-55结合竞争的能力以及在人多巴胺，5-羟色胺和去甲肾上腺素转运蛋白上抑制神经递质再摄取的能力。基于效力（例如，K i  = 800 pM）和显着的功能选择性（例如，人多巴胺：5-羟色胺或去甲肾上腺素：5-羟色胺的IC 50比，⩾1397）被确定为高效和选择性的5-羟色胺再摄取抑制剂。在结合亲和力和再摄取抑制中起主要作用的最佳特征包括芳族部分上的亲脂取代，反式2,5-二取代的四氢呋喃环的相对
• Modulators of Central Nervous System Neurotransmitters
  申请人：Cashman John

  公开号：US20080261967A1

  公开（公告）日：2008-10-23

  Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.

  本发明涉及具有药理活性的药物，特别是针对细胞受体和细胞内信号传导的药物，尤其是中枢神经系统（CNS）神经递质的受体和信号通路。本发明还涉及使用这些药物的相关方法和组合物，用于治疗或预防疾病或障碍。
• Modulators of central nervous system neurotransmitters
  申请人：Human BioMolecular Research Institute

  公开号：US08168635B2

  公开（公告）日：2012-05-01

  Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.

  本发明涉及一种具有药理活性的制剂，可用于靶向细胞受体和细胞内信号通路，特别是中枢神经系统（CNS）神经递质的受体和信号通路。同时，本发明还涉及使用该制剂进行疾病或障碍的治疗或预防的相关方法和组合物。
• MODULATORS OF CENTRAL NERVOUS SYSTEM NEUROTRANSMITTERS
  申请人：CASHMAN John

  公开号：US20130123253A1

  公开（公告）日：2013-05-16

  Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.

  本发明涉及一种对细胞受体和细胞内信号传导具有药理活性的药剂，特别是针对中枢神经系统（CNS）神经递质的受体和信号通路。本发明还涉及使用这些药剂的相关方法和组合物，用于治疗或预防疾病或障碍。
• Site‐Selective Ortho/Ipso C−H Difunctionalizations of Arenes using Thianthrene as a Leaving Group
  作者：Dorian Dupommier、Martin Vuagnat、Javid Rzayev、Sourav Roy、Philippe Jubault、Tatiana Besset

  DOI：10.1002/anie.202403950

  日期：2024.7.22

  Through the development of a “C−H thianthrenation/Catellani” strategy, the regioselective C−H difunctionalization of various non-prefunctionalized arenes was successfully achieved. Starting from thianthrenium salts and using a commercially available norbornene, this approach will further open the chemical space of late-stage functionalization.

  通过开发“C−H thianthrenation/Catellani”策略，成功实现了各种非预官能化芳烃的区域选择性C−H双官能化。从铊盐开始并使用市售的降冰片烯，这种方法将进一步打开后期功能化的化学空间。